<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Reduced-intensity conditioning (RIC) was given to the patients above 55 years old (≥55 years), while myeloablative conditioning regimens (MACs) were designed for patients below 55 years old (&lt;55 years). The conditioning regimens for myeloid malignancies including AML, MDS and CMML were based on intravenous busulfan 3.2 mg/kg/day for 3 days in MACs (2 days in RIC), fludarabine 30 mg/m
 <sup>2</sup>/day and cytarabine (Ara-C) 1−2 g/m
 <sup>2</sup>/day for 5 days. All the patients with ALL received MAC regimen, which consisted of total body irradiation (10 Gy in five fractions), cyclophosphamide (60 mg/kg/day for 2 days) and etoposide (15 mg/kg/day for 2 days) (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>)
</p>
